I
ImmuNext
11 employees
ImmuNext is a develops compounds on the cutting edge of immunotherapy for cancer.
Basic info
Industry
biotechnology research
Sectors
CD40L
Biotechnology
VISTA
autoimmunity
immuno-oncology
checkpoint regulator
immunomodulatory
Date founded
2011
FAQ
How to get an intro to ImmuNext?
